RICHARD CARPENTER: Open Payments
NPI 1881127165 · MARTINEZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 50 payments from 18 companies in 2025. Trend: 2023 $891 · 2024 $1,061 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $145 |
| AstraZeneca Pharmaceuticals LP | 4 | $142 |
| Otsuka America Pharmaceutical, Inc. | 5 | $140 |
| ABBVIE INC. | 5 | $116 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| Lundbeck LLC | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 2 | $69 |
| Novo Nordisk Inc | 3 | $67 |
| PFIZER INC. | 3 | $50 |
| Exact Sciences Corporation | 2 | $49 |
Products named: REXULTI, CAPLYTA, AIRSUPRA, HETLIOZ, QULIPTA, ABILIFY MAINTENA, SHINGRIX, VRAYLAR.
Industry payments across CA — which companies pay providers there.
